Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational InsightsAllison L. Brodsky, Shannon N. Westin|Clinical Cancer Research|2026Cited by 0